Progen Pharmaceuticals Limited (PGLA) Expands Drug Development Pipeline Through Acquisition of CellGate, Inc.
2/4/2008 7:36:50 AM
More...
|
CellGate, Inc. Initiates Phase I Clinical Study In Age-Related Macular Degeneration
11/8/2006 9:53:14 AM
More...
|
CellGate, Inc. Commences Phase II Clinical Trial Of Anticancer Compound CGC-11047 For Prostate Cancer
11/1/2006 10:43:37 AM
More...
|
CellGate, Inc. Initiates Innovative Phase Ib Clinical Study Of Anti-proliferative Agent, CGC-11047, In Advanced Solid Tumors And Lymphomas
10/2/2006 9:56:49 AM
More...
|
Isotechnika Inc. (ISA.TO) Signs Option Agreement For Topical Delivery Technology Of ISA247
4/25/2006 10:46:19 AM
More...
|